BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma

Taiyo Pharma Tech to establish gene therapy manufacturing using Cytiva’s FlexFactory™ solution

In a race to become one of the first contract manufacturers to enter the Japanese domestic gene therapy market, Taiyo Pharma Tech Co., Ltd. will establish ...

December 10, 2021 | News

GSK Provides Update on Manufacturing Operations in Singapore

Amoxicillin is an active pharmaceutical ingredient (API) in GSK's Augmentin product. This will result in the closure of the site, with manufacturing at the...

December 08, 2021 | News

FUJIFILM Irvine Scientific Establishes a Bioprocessing Innovation and Collaboration Center in China

FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproducti...

December 03, 2021 | News

Prestige BioPharma Announces Grand Opening of Global-Scale Vaccine Center in South Korea

The opening ceremony was held on December 01, 2021 at the Vaccine Center in Osong Campus. The ceremony was attended by many distinguished guests including ...

December 02, 2021 | News

10x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth Consecutive Year

10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced that Chromium X has been name...

December 02, 2021 | News

First GMP Production at 24,000L Line of MFG5 Facility Successfully Completed at WuXi Biologics

WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has successf...

November 26, 2021 | News

Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region

Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to Asia" serv...

November 25, 2021 | News

PARACRINE Receives Full FDA Approval to Launch Pivotal Trial in Diabetic Foot Ulcer Patients

Pivotal trial to support marketing approval of regenerative cells processed with the Celution® System to commence in Q1 2022 Paracrine, Inc. ann...

November 18, 2021 | News

FDA Approves Treatment for Rare Blood Disease

Today, the U.S. Food and Drug Administration approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood dise...

November 15, 2021 | News

Hetero and Shenzhen Beimei Pharmaceuticals launch antiviral drug Oselavir® in China

Hetero, a globally renowned vertically integrated pharmaceutical organization and Shenzhen Beimei Pharmaceuticals jointly announced that they have received...

November 12, 2021 | News

Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Japanese government will purch...

November 11, 2021 | News

Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers

Wastewater-based epidemiology can help communities monitor infection dynamics for SARS-CoV-2 and can serve as an early-warning system for the virus in a po...

November 10, 2021 | News

Biosynth Carbosynth and Shengquan Acquire New Plant to Increase Production Capacities in China

The more than 30,000 square meter property contains a comprehensive factory building on 5 floors, a demo workshop and a large warehouse including a state-o...

November 09, 2021 | News

Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World

Applications Remain Under Review by Other Regulatory Authorities, Including U.S. Food and Drug Administration and the European Medicines Agency Merck (NYS...

November 08, 2021 | News

Stay Connected